8 Results for "

P2+Receptor

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "P2+Receptor" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-15568
CAS No.: 475205-49-3
Purity:  98.64%
A-317491 is a potent, selective and non-nucleotide antagonist of P2X3 and P2X2/3 receptors, with Kis of 22, 22, 9, and 92 nM for hP2X3, rP2X3, hP2X2/3, and rP2X2/3, respectively. A-317491 is highly selective (IC50>10 μM) over other P2 receptors and other neurotransmitter receptors, ion channels, and enzymes. A-317491 reduces inflammatory and neuropathic pain by blocking P2X3 and P2X2/3 receptor-mediated calcium flux [2].
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-15568A
Purity:  99.88%
A-317491 sodium salt hydrate is a potent, selective and non-nucleotide antagonist of P2X3 and P2X2/3 receptors, with Kis of 22, 22, 9, and 92 nM for hP2X3, rP2X3, hP2X2/3, and rP2X2/3, respectively. A-317491 sodium salt hydrate is highly selective (IC50>10 μM) over other P2 receptors and other neurotransmitter receptors, ion channels, and enzymes. A-317491 sodium salt hydrate reduces inflammatory and neuropathic pain by blocking P2X3 and P2X2/3 receptor-mediated calcium flux [2].
loading...
    loading...
Cat. No.: HY-137888A
CAS No.: 71997-40-5
Purity:  ≥98.0%
Synonyms: oATP trisodium salt
Oxidized ATP (oATP) trisodium salt is a broad-spectrum P2 receptor inhibitor. Oxidized ATP trisodium salt irreversibly antagonizes P2X7R activation. Oxidized ATP trisodium salt inhibits c-reactive protein (CRP)-induced NLRP3 inflammasome activation. Oxidized ATP trisodium salt can be used for research of atherosclerosis [2].
loading...
    loading...
Cat. No.: HY-120409
CAS No.: 1463912-49-3
Target:  

LPL Receptor Apoptosis

Research Areas:  

Cancer

AB1 is a highly selective S1P2 receptor antagonist (IC50=3.5 nM). AB1 inhibits sphingosine-1-phosphate (S1P) signaling, suppressing tumor cell migration, angiogenesis, and profibrotic mediator CTGF expression while inducing apoptosis. AB1 is promising for research of solid tumors .
loading...
    loading...
Cat. No.: HY-101370
CAS No.: 100020-57-3
Purity:  ≥98.0%
Target:  

P2X Receptor

Research Areas:  

Metabolic Disease

2-Methylthio-ATP tetrasodium is a non-specific P2-receptor agonist. 2-Methylthio-ATP tetrasodium causes noncompetitive inhibition of ADP-induced human platelet aggregation .
loading...
    loading...
Cat. No.: HY-176057
CAS No.: 2677041-36-8
Target:  

β-catenin

Research Areas:  

Inflammation/Immunology

S118 is an orally active sphingosine-1-phosphate receptor 2 (S1P2 receptor) inhibitor. S118 prevents the binding of the S1P2 receptor to dapper1 (Dpr1), reduces the accumulation of β-catenin and blocks the nuclear translocation of the S1P2 receptor, thereby inhibiting inflammation, fibrosis, and epithelial-mesenchymal transition (EMT) and exerting anti-idiopathic pulmonary fibrosis (IPF) activity. S118 is promising for research of idiopathic pulmonary fibrosis .
loading...
    loading...
Cat. No.: HY-134370
CAS No.: 10527-46-5
Target:  

P2X Receptor

Research Areas:  

Cardiovascular Disease

Ap4G is a dinucleoside polyphosphate compound with vasoconstrictor activity. Ap4G regulates vasoconstriction through P2 receptors, especially P2X receptors, and is an important tool for studying vascular physiology and pathology .
loading...
    loading...
Cat. No.: HY-182642
CAS No.: 436847-13-1
MRS2339 is a ribose-modified nucleotide and a nucleotidase-resistant P2 receptor agonist. MRS2339 activates P2X4R. MRS2339 induces ionic currents via P2X receptors, reduces cardiomyocyte cross-sectional area and heart weight/body weight ratio, lacks vasodilatory activity, and extends the lifespan of mice with cardiomyopathy. MRS2339 can be used in research related to heart failure and cardiomyopathy [2].
loading...
    loading...